Connect with us

Headlines of The Day

Kotak Mahindra comes up with new healthcare fund

It is an open ended equity scheme investing in Pharma, Healthcare & allied sectors.

Accordingly, the investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved.

Under normal circumstances, Kotak Healthcare Fund will hold an allocation of 80% to 100% in Equity and Equity Related Securities of companies engaged in Pharma, healthcare & allied sectors, 0% to 20% in Other Equity and Equity Related Securities of companies, 0% to 20% in Overseas Mutual Funds schemes / ETFs / Foreign Securities, 0% to 20% in Debt and Money Market Securities and 0% to 10% in Units issued by REITs & InvITs.

As per the Scheme Information Document, Kotak Healthcare Fund aims to provide long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied sectors.

The scheme would be agnostic to market capitalization and may take concentrated exposure to certain stocks. Investment will be made in stocks of companies engaged in research & development, manufacturing, active pharmaceutical ingredients, pharma related chemicals, biological drugs and related products, distribution & sales of the entire spectrum of Pharmaceutical products including intermediates, medical equipment and accessories & personal healthcare products. Although the scheme will predominantly invest in stocks as per the Pharma & Healthcare sector, it retains the flexibility to take some exposure beyond the sector based on the asset allocation pattern of the scheme.

Kotak Healthcare Fund offers exposure to India’s thriving healthcare sector and its performance will be benchmarked against Nifty Healthcare Index TRI

The scheme will be managed by Ms Shibani Sircar Kurian and Dhananjay Tikariha (for equity), Abhishek Bisen (for debt) and Arjun Khanna (for overseas investments).

The NFO opens for subscription on November 20, 2023 and closes on December 04, 2023. The schemes will reopen for continuous sale and repurchase on December 18, 2023.

The minimum subscription amount is Rs 5,000/- and in multiples of Re.1/- thereof.

The scheme offers Regular Plan and Direct Plan each plan offers Growth option and Income Distribution cum capital withdrawal Option (IDCW). PersonalFN

Copyright © 2024 Medical Buyer

error: Content is protected !!